Genomic Medicine Program Advisory Committee; Meeting, 20340 [2020-07623]

Download as PDF 20340 Federal Register / Vol. 85, No. 70 / Friday, April 10, 2020 / Notices Subcommittee meeting in San Antonio, Texas will be reviewed. The Subcommittee will consider action to approve. • Draft minutes from the March 19, 2020 Education and Training Subcommittee meeting via teleconference will be reviewed. The Subcommittee will consider action to approve. V. Update on Education and Training Modules—UCR Technology Director The UCR Technology Director will review the development of each of the three education and training modules (Enforcement, UCR 101, and National Registration System), including format and budget. The Subcommittee will discuss and provide comments on the education and training modules. VI. Role of Subcommittee in Development of Modules—UCR Technology Director The UCR Technology Director will lead a discussion on the need for assistance and guidance from the Subcommittee in the development of the modules. lotter on DSKBCFDHB2PROD with NOTICES VIII. Other Items—Subcommittee Chair The Subcommittee Chair will call for any other items the Subcommittee members would like to discuss. 18:00 Apr 09, 2020 Jkt 250001 Chair will adjourn the meeting. The agenda will be available no later than 5:00 p.m. Eastern time, April 8, 2020 at: https://plan.ucr.gov. CONTACT PERSON FOR MORE INFORMATION: Elizabeth Leaman, Chair, Unified Carrier Registration Plan Board of Directors, (617) 305–3783, eleaman@ board.ucr.gov. Alex B. Leath, Chief Legal Officer, Unified Carrier Registration Plan. [FR Doc. 2020–07693 Filed 4–8–20; 11:15 am] BILLING CODE 4910–YL–P DEPARTMENT OF VETERANS AFFAIRS Genomic Medicine Program Advisory Committee; Meeting VII. Planning for Education and Training Sessions at June 8, 2020 Meeting—Subcommittee Chair The Subcommittee Chair will report on the latest plans for UCR to host several live education and training sessions at the summer meeting on June 8, 2020 in Portland, Oregon. VerDate Sep<11>2014 IX. Adjournment—Subcommittee Chair The Department of Veterans Affairs (VA) gives notice under the Federal Advisory Committee Act, that a meeting of the Genomic Medicine Program Advisory Committee (the Committee) will be held on Wednesday April 29, 2020, via teleconference. The meeting will begin at 11:00 a.m. EST and adjourn at 3:00 p.m. EDT. The meeting is open to the public on VANTS 1–800– 767–1750 CODE 94273#. The purpose of the Committee is to provide advice and make recommendations to the Secretary of Veterans Affairs on using genetic information to optimize medical care for Veterans and to enhance development of tests and treatments for diseases particularly relevant to Veterans. PO 00000 Frm 00102 Fmt 4703 Sfmt 9990 On April 29, 2020, the Committee will receive updated briefings on various VA research programs, including the Million Veteran Program (MVP) to ascertain the progress of the program in the areas of participant recruitment, data generation and storage, and data access. The Committee will also receive updates from ongoing MVP endeavors, including cohort building, data generation and usage, return of results and a new mental health initiative. Additionally, the Committee will discuss and explore potential recommendations to be included in the next annual report. Public comments will be received at 2:30 p.m. and are limited to 5 minutes each. Individuals who speak are invited to submit a 1–2 page summary of their comments for inclusion in the official meeting record to Jennifer Moser, Designated Federal Officer, Office of Research and Development (10X2), 810 Vermont Avenue NW, Washington, DC 20420, or via email at Jennifer.Moser@ va.gov. In the communication, writers must identify themselves and state the organization, association or person(s) they represent. Any member of the public who wishes to attend the teleconference should RSVP to Jennifer Moser at (202) 510–4253 no later than close of business, April 22, 2020, at the phone number or email address noted above. Dated: April 7, 2020. LaTonya L. Small, Federal Advisory Committee Management Officer. [FR Doc. 2020–07623 Filed 4–9–20; 8:45 am] BILLING CODE 8320–01–P E:\FR\FM\10APN1.SGM 10APN1

Agencies

[Federal Register Volume 85, Number 70 (Friday, April 10, 2020)]
[Notices]
[Page 20340]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-07623]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Genomic Medicine Program Advisory Committee; Meeting

    The Department of Veterans Affairs (VA) gives notice under the 
Federal Advisory Committee Act, that a meeting of the Genomic Medicine 
Program Advisory Committee (the Committee) will be held on Wednesday 
April 29, 2020, via teleconference. The meeting will begin at 11:00 
a.m. EST and adjourn at 3:00 p.m. EDT. The meeting is open to the 
public on VANTS 1-800-767-1750 CODE 94273#.
    The purpose of the Committee is to provide advice and make 
recommendations to the Secretary of Veterans Affairs on using genetic 
information to optimize medical care for Veterans and to enhance 
development of tests and treatments for diseases particularly relevant 
to Veterans.
    On April 29, 2020, the Committee will receive updated briefings on 
various VA research programs, including the Million Veteran Program 
(MVP) to ascertain the progress of the program in the areas of 
participant recruitment, data generation and storage, and data access. 
The Committee will also receive updates from ongoing MVP endeavors, 
including cohort building, data generation and usage, return of results 
and a new mental health initiative. Additionally, the Committee will 
discuss and explore potential recommendations to be included in the 
next annual report.
    Public comments will be received at 2:30 p.m. and are limited to 5 
minutes each. Individuals who speak are invited to submit a 1-2 page 
summary of their comments for inclusion in the official meeting record 
to Jennifer Moser, Designated Federal Officer, Office of Research and 
Development (10X2), 810 Vermont Avenue NW, Washington, DC 20420, or via 
email at [email protected]. In the communication, writers must 
identify themselves and state the organization, association or 
person(s) they represent. Any member of the public who wishes to attend 
the teleconference should RSVP to Jennifer Moser at (202) 510-4253 no 
later than close of business, April 22, 2020, at the phone number or 
email address noted above.

    Dated: April 7, 2020.
LaTonya L. Small,
Federal Advisory Committee Management Officer.
[FR Doc. 2020-07623 Filed 4-9-20; 8:45 am]
 BILLING CODE 8320-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.